Towercrest Capital Management Bristol Myers Squibb CO Transaction History
Towercrest Capital Management
- $537 Million
- Q1 2025
A detailed history of Towercrest Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Towercrest Capital Management holds 3,502 shares of BMY stock, worth $160,426. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,502
Previous 3,757
6.79%
Holding current value
$160,426
Previous $212,000
0.47%
% of portfolio
0.04%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,800Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.7M-
Vanguard Group Inc Valley Forge, PA191MShares$8.77 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.27 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.95 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.34 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.04 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...